News and Announcements
MedAdvisor Quarterly Report June 2016: Strong Operational Performance, Cash Receipts Totals $292k, Pharmacy Network and Number of Patients Increases
- Published August 02, 2016 3:12PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
29th July 2016, ASX Announcement
Highlights
- Strong operational performance with an increase across all key revenue drivers
– Over 180,000 patients using the platform as at 30 June 2016, a 132% increase on the prior corresponding period
– Expansion of pharmacy network by 33% on the prior corresponding period to over 1,600 pharmacies, encompassing over 30% of all Australian community pharmacies
– Key partnerships with pharmaceutical manufacturers for Patient Engagement Programs (PEP) - Cash receipts for the quarter totalled $292k, an increase of 7% on the previous March 2016 quarter
- Tap-To-Refill script ordering function continues to perform, becoming a key drover of patient engagement, with 40% of the user base currently utilising the function
- MedAdvisor continues to expand its pharmacy network and increase the number of patients on the platform , driving transactional and subscription revenue
MedAdvisor Limited (ASX: MDR, the Company), Australia’s leading digital medication management company, has today released its Appendix 4C Report for the three-month period to 30 June 2016 and is pleased to provide a review of the progress during the period.
To view the full announcement, please click on the button below.